Castle Biosciences, Inc.CSTLNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
3Y CAGR+49.9%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+49.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.4x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$13.30M+3.1%
2024$12.89M+21.5%
2023$10.61M+168.6%
2022$3.95M+5797.0%
2021$67000.00+101.8%
2020$-3.66M-84.8%
2019$-1.98M+21.5%
2018$-2.52M-72.7%
2017$-1.46M-